Lombard Odier Asset Management (Switzerland)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,630
| Closed | -$1.34M | – | 329 |
|
|
2023
Q1 | $1.34M | Buy |
1,630
+163
| +11% | +$134K | 0.12% | 158 |
|
|
2022
Q4 | $1.06M | Buy |
1,467
+601
| +69% | +$434K | 0.08% | 176 |
|
|
2022
Q3 | $597K | Sell |
866
-482
| -36% | -$332K | 0.05% | 182 |
|
|
2022
Q2 | $797K | Buy |
+1,348
| New | +$797K | 0.07% | 171 |
|
|
2022
Q1 | – | Sell |
-999
| Closed | -$631K | – | 346 |
|
|
2021
Q4 | $631K | Buy |
+999
| New | +$631K | 0.04% | 208 |
|
|
2021
Q3 | – | Sell |
-1,161
| Closed | -$648K | – | 423 |
|
|
2021
Q2 | $648K | Sell |
1,161
-133
| -10% | -$74.2K | 0.03% | 276 |
|
|
2021
Q1 | $612K | Buy |
+1,294
| New | +$612K | 0.04% | 214 |
|
|
2020
Q4 | – | Sell |
-2,933
| Closed | -$1.64M | – | 305 |
|
|
2020
Q3 | $1.64M | Buy |
+2,933
| New | +$1.64M | 0.17% | 88 |
|
|
2020
Q2 | – | Sell |
-2,625
| Closed | -$1.28M | – | 292 |
|
|
2020
Q1 | $1.28M | Buy |
+2,625
| New | +$1.28M | 0.17% | 92 |
|
|
2019
Q3 | – | Sell |
-1,305
| Closed | -$408K | – | 374 |
|
|
2019
Q2 | $408K | Hold |
1,305
| – | – | 0.04% | 252 |
|
|
2019
Q1 | $536K | Buy |
+1,305
| New | +$536K | 0.05% | 232 |
|
|
2016
Q2 | – | Sell |
-393
| Closed | -$142K | – | 413 |
|
|
2016
Q1 | $142K | Hold |
393
| – | – | 0.02% | 309 |
|
|
2015
Q4 | $216K | Buy |
+393
| New | +$216K | 0.03% | 252 |
|
|
2015
Q3 | – | Sell |
-393
| Closed | -$200K | – | 381 |
|
|
2015
Q2 | $200K | Sell |
393
-216
| -35% | -$110K | 0.02% | 416 |
|
|
2015
Q1 | $276K | Buy |
+609
| New | +$276K | 0.03% | 335 |
|
|
2014
Q4 | – | Sell |
-52,917
| Closed | -$19.1M | – | 626 |
|
|
2014
Q3 | $19.1M | Buy |
52,917
+51,985
| +5,578% | +$18.8M | 0.49% | 48 |
|
|
2014
Q2 | $262K | Buy |
+932
| New | +$262K | 0.03% | 321 |
|